[1] XIE X,GOU W L. Obstetrics and gynaecology[M]. Beijing:People's Medical Publishing House,2015. [2] 刘冬娥. 女性围绝经期的生理和病理变化[J]. 中国实用妇科与产科杂志,2004,20(8):473-474. [3] 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南(2018)[J]. 中华妇产科杂志,2018,53(11):729- 739. [4] 程艳梅,史惠蓉. 医务人员对绝经综合征和绝经激素治疗的认知现状调查[J]. 中国计划生育和妇产科,2016,8(4):36-39. [5] 曹泽毅. 中华妇产科学(下册)[M]. 2版. 北京:人民卫生出版社,2005:2537. [6] TAO M,SHAO H,LI C,et al. Correlation between the modified Kupperman index and the menopause rating scale in Chinese women[J]. Patient Prefer Adherence,2013(7):223-229. [7] GARTOULLA P,BELL R J,WORSLEY R,et al. Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife[J]. Maturitas,2015,81(4):487-492. [8] PACHMAN D R,JONES J M,LOPRINZI C L. Management of menopause-associated vasomotor symptoms:current treatment options,challenges and future directions[J]. Int J Women's Health,2010(2):123-135. [9] SRIPRASERT I,PANTASRI T,PIYAMONGKOL W,et al. An international menopause society study of vasomotor symptoms in Bangkok and Chiang Mai,Thailand[J]. Climacteric,2017,20(2):171-177. [10]杨林,郑燕伟,杜莉,等. 上海市围绝经期门诊就诊妇女治疗效果的随访研究[J].中华生殖与避孕杂志,2018,38(6):454-459. [11]LAN Y,HUANG Y,SONG Y,et al. Prevalence,severity,and associated factors of menopausal symptoms in middle-aged Chinese women:a community-based cross-sectional study in southeast China[J]. Menopause,2017,24(10):1200-1207. [12]ISAACS A J,BRITTON A R,MCPHERSON K. Why do women doctors in the UK take hormone replacement therapy?[J]. J Epidemiol Community Health,1997,51(4):373-377. [13]李颖,郁琦,马良坤,等.北京市城区围绝经期妇女更年期症状分析[J]. 生殖医学杂志,2008,17(5):329-334. [14]朱连红,马麟娟,许正芬,等. 对围绝经期妇女激素补充治疗的认知度调查[J]. 中华生殖与避孕杂志,2017,37(6):480- 484. [15]中华医学会妇产科学分会绝经学组. 绝经期管理与激素补充治疗临床应用指南(2012版)[J]. 中华妇产科杂志,2013,48(10):795-799. [16]CHU K,SONG Y,CHATOOAH N D,et al. The use and discontinuation of hormone replacement therapy in women in South China[J]. Climacteric,2018,21(1):47-52.